Literature DB >> 2499459

Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).

P Schuff-Werner1, E Schütz, W C Seyde, T Eisenhauer, G Janning, V W Armstrong, D Seidel.   

Abstract

Heparin-induced Extracorporeal LDL-Precipitation (HELP) is an effective procedure for the elimination of both plasma LDL and fibrinogen. In 10 adult patients with severe type II hyperlipoproteinemia, a single HELP treatment of 3 1 plasma led to an acute decrease in the average plasma viscosity (PV) from 1.30 to 1.1 mPas. At the same time, an even more marked decrease in the mean erythrocyte aggregation rate from a pathological value of 7.9% to a value of 3.7% (normal range less than 5%) was observed. Long-term studies on five patients demonstrated a lasting improvement in these two haemorheological variables. The acute rheological changes were also accompanied by an improvement in polarographically determined muscle oxygen tension. Mean oxygen tension values measured in both the m.biceps brachii and the m.tibialis anterior in five patients before and after a single HELP treatment increased from 30 +/- 4 to 37 +/- 7 mmHg and from 27 +/- 2 to 31 +/- 3 mmHg respectively. These results may provide an explanation for the rapid improvement in patients' clinical symptoms such as angina pectoris and in stress electrocardiogram which have been observed during HELP therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499459     DOI: 10.1111/j.1365-2362.1989.tb00192.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

Review 1.  [Rheological determinants of end-organ damage].

Authors:  M Leschke; W Klimek; F Jung
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

2.  A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss.

Authors:  D Ullrich; G Aurbach; C Drobik
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

3.  Application of HELP in nonarteritic anterior ischemic optic neuropathy: a prospective, randomized, controlled study.

Authors:  A Haas; M Walzl; F Jesenik; B Walzl; A Berghold; J Berglöff; B Feigl; J Faulborn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

4.  [Coronary heart disease in childhood in familial hypercholesteremia. Maximum therapy with LDL apheresis].

Authors:  K P Mellwig; H K Schmidt; A Brettschneider-Meyer; H Meyer; B R Jaeger; A K Walli; D Seidel; D Horstkotte
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

5.  Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: does it influence cerebral hemodynamics?

Authors:  A Iannuzzi; G Bianciardi; F Faccenda; A Gnasso; N Scarpato; L Di Marino; G Iaccarino; C Simoes; G Sacchi; E Weber
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia.

Authors:  Y Levy; R Leibowitz; M Aviram; J G Brook; U Cogan
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

7.  Lipid apheresis: oxidative stress, rheology, and vasodilatation.

Authors:  K-P Mellwig; E Pulawski; D Horstkotte; F van Buuren
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

8.  Haemorheological treatment of ischaemia--facts or fancy?

Authors:  E Ernst
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

9.  Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution CMR--a comparative analysis.

Authors:  Jochen M Grimm; Konstantin Nikolaou; Andreas Schindler; Reinhard Hettich; Franz Heigl; Clemens C Cyran; Florian Schwarz; Reinhard Klingel; Anna Karpinska; Chun Yuan; Martin Dichgans; Maximilian F Reiser; Tobias Saam
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-29       Impact factor: 5.364

10.  Role of lipid apheresis in changing times.

Authors:  Peter Schuff-Werner; Sebastian Fenger; Peter Kohlschein
Journal:  Clin Res Cardiol Suppl       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.